These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 19306994

  • 1. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 2. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 3. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
    Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL.
    Cancer Res; 2000 Jul 01; 60(13):3542-9. PubMed ID: 10910067
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
    Yang W, Feng J, Chang X, Fu T, Ye X, Zhang H, Li X, Wen H, Feng L, Tong C, Cui H.
    Gynecol Oncol; 2007 Apr 01; 105(1):238-43. PubMed ID: 17383546
    [Abstract] [Full Text] [Related]

  • 5. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.
    Cancer Res; 2002 Apr 15; 62(8):2347-52. PubMed ID: 11956095
    [Abstract] [Full Text] [Related]

  • 6. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
    Yang WL, Cui H, Feng J, Chang XH, Fu TY, Ye X, Zhang H, Li XP, Wen HW, Feng LM, Tong CR.
    Ai Zheng; 2004 Dec 15; 23(12):1639-45. PubMed ID: 15601552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells.
    Galetto A, Contarini M, Sapino A, Cassoni P, Consalvo E, Forno S, Pezzi C, Barnaba V, Mussa A, Matera L.
    J Surg Res; 2001 Sep 15; 100(1):32-8. PubMed ID: 11516202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD, Luo RC, Ding ZH, Lu F, Yuan CQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug 15; 26(8):1184-7. PubMed ID: 16939917
    [Abstract] [Full Text] [Related]

  • 12. [rAAV/BA46-transfected dendritic cells can induce specific cellular immunity].
    You CX, Su J, Liao WJ, Zhang JY, Liu Y, Paul LH, Luo RC.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec 15; 28(12):2146-9. PubMed ID: 19114342
    [Abstract] [Full Text] [Related]

  • 13. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J.
    J Immunother; 2006 Dec 15; 29(5):545-57. PubMed ID: 16971810
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
    Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH.
    Clin Cancer Res; 2003 Apr 15; 9(4):1517-27. PubMed ID: 12684428
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo expansion of antitumor cytotoxic lymphocytes with tumor-associated antigen-loaded dendritic cells.
    Gervais A, Bouet-Toussaint F, Toutirais O, De La Pintiere CT, Genetet N, Catros-Quemener V.
    Anticancer Res; 2005 Apr 15; 25(3B):2177-85. PubMed ID: 16158961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.